Lisondra, Novelyn .
HRN: 22-13-71 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2023
CEFTRIAXONE 1G (VIAL)
11/17/2023
11/24/2023
IV DRIP
980mg
Q24
AGE With Severe Dehydration
Checking Final Appropriateness
11/20/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/20/2023
11/27/2023
IV
1000mg
Q8H
Sepsis
Checking Final Appropriateness
11/20/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/20/2023
11/27/2023
IV
70mg
Q8H
Sepsis
Checking Final Appropriateness
11/23/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
11/23/2023
11/30/2023
TOPICAL
25g
TID
Burn; Sepsis
Checking Final Appropriateness
11/23/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
11/23/2023
11/30/2023
IV
120mg; 60mg
OD
Sepsis
Checking Final Appropriateness